Business, energy, technology, markets and global industry news from Business News Today

NVIDIA

PharmaDeviceNews NVIDIA
Sentante’s CE-marked endovascular robotic platform combines catheter control, force sensing, medical imaging and procedural data capture to build a foundation for future physical AI-assisted vascular interventions. Representative image.
Medical Devices & Diagnostics

What Sentante’s physical AI strategy means for remote endovascular surgery in Europe

Sentante is using its CE-marked endovascular robot to capture force, motion and imaging data, but its clinical AI value still needs proof.

Read More
A radiologist reviews AI-assisted chest CT scans as HOPPR expands developer access to medical imaging foundation models with its new chest CT narrative model. Representative image.
Medical Devices & Diagnostics

HOPPR’s chest CT model tackles radiology’s hardest AI test, but validation will decide what comes next

HOPPR adds a chest CT narrative model, widening developer access while leaving validation, regulation and workflow adoption as the key tests.

Read More
Representative image of an AI-powered drug discovery lab, showcasing robotics, molecular modeling, and digital twin simulations—core elements of the NVIDIA and Eli Lilly co-innovation initiative to transform pharmaceutical R&D.
Pharma & Biotech

Lilly and NVIDIA commit $1bn to AI co-innovation lab for next-gen drug discovery

Eli Lilly and Company and NVIDIA have announced the formation of a co-innovation lab aimed at accelerating drug discovery using AI, robotics, and advanced compute. With a planned $1 billion investment over five years, the lab will leverage NVIDIA’s BioNeMo platform and Vera Rubin architecture alongside Lilly’s drug development expertise. The initiative represents one of

Read More